Close Menu

NEW YORK (GenomeWeb) – IsoPlexis said today that it has raised $25 million in a Series C financing round.

The round was led by Northpond Ventures and included what the company called "new strategic investment," as well as funds from current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.